SCHEMBL5659570

SCHEMBL5659570

CCOC(=O)C(Cc1ccc(OCCc2nc(-c3ccccc3)cc(=O)n2CC)cc1)OCC

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 18/20 0.47
PPARG P37231 17/20 0.47
PPARD Q03181 5/20 0.45
GSK3B P49841 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660094 0.93 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL5658450 0.90 PPARA (0.50) PPARAPPARGPPARD
SCHEMBL5659043 0.88 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL5659373 0.86 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL5659214 0.84 PPARA (0.51) PPARAPPARGPPARD
SCHEMBL5658406 0.83 PPARG (0.58) PPARAPPARGPPARD
SCHEMBL5655756 0.81 PPARA (0.49) PPARAPPARGPPARD
SCHEMBL14602222 0.81 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL5657691 0.81 PPARG (0.60) PPARAPPARGPPARD
SCHEMBL14602219 0.81 PPARG (0.60) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103215-A1 New monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION & REDDY-CHEMINOR, INC. 2002-08-01 US claimed
US-6369067-B1 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-04-09 US claimed
US-7157581-B2 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-02 US disclosed
US-7157581-B2 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-02 US disclosed
US-7157581-B2 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-02 US disclosed
US-7053217-B2 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2006-05-30 US disclosed
US-20020103215-A1 New monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION & REDDY-CHEMINOR, INC. 2002-08-01 US disclosed
US-6369067-B1 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103215-A1 New monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them CYP11B1, CYP46A1, CYP27A1 PPARA 176/4885PPARG 133/4885PPARD 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.